Pediatric Hematology/Oncology

Aplastic Anemia

Questions discussed in this category

When do you refer AYA patients with newly diagnosed severe aplastic anemia for transplant?

Would you give a trial of IST first or immediately refer for SCT if the patient has matched siblings?

How do you manage prophylactic antimicrobial medications in patients who undergo ATG/cyclosporine/eltrombopag induction for severe aplastic anemia?

What would you recommend within the first year after ATG and thereafter if still maintained on cyclosporine?

1 Answer available

How soon do you anticipate response to cyclosporine in red cell aplasia and what cyclosporine trough levels do you target?

1 Answer available

In what situations do you recommend upfront haploidentical transplant in a pediatric patient with newly diagnosed idiopathic severe aplastic anemia who does not have a MSD/MUD donor?

1 Answer available

How would you approach immunosuppression for patients with severe aplastic anemia who are not transplant or ATG candidates?

Such as patients who are frail, elderly, renally impaired? Would you consider sirolimus over cyclosporine or tacrolimus for safer nephrotoxicity prof...

1 Answer available

Would you stop current immunosuppressive therapy or delay starting immunosuppressive therapy in a patient with aplastic anemia who has been infected with COVID-19?

2 Answers available

Papers discussed in this category

Blood, 2013 Sep 19

Management of the refractory aplastic anemia patient: what are the options?

The Lancet. Haematology, 2015-09

Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study.

Haematologica, 2017-07

Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia.

Pediatric Hematology/Oncology

Aplastic Anemia

Questions discussed in this category

Papers discussed in this category

Related Topics in Pediatric Hematology/Oncology